T1	Participants 49 64	multiple myelom
T2	Participants 228 260	newly diagnosed multiple myeloma
T3	Participants 735 882	524 (90.2%) of 581 patients enrolled in the NMSG 4/90 completed the first questionnaire, and 484 (83.3%) completed all questionnaires given to them
T4	Participants 646 733	questionnaire was completed prior to treatment and after 1, 6, 12, 24, 36 and 48 months
